Catalyst
Slingshot members are tracking this event:
FORWARD-5 data read out for ALKS-5461 in Treatment Resistant Depression (TRD), the 3rd of 3 Phase 3 trials currently underway
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ALKS |
|
|
||||
Additional Information
Estimated Study Completion Date:October 2016
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 21, 2016
Occurred Source:
http://phx.corporate-ir.net/phoenix.zhtml?c=92211&p=irol-newsArticle&ID=2213519
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Alks-5461, Trd, Treatment Resistant Depression, Phase 3
